Vimarsana
Biggest News Aggregation in the World

Page 25 - Collaborative Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Collaborative Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Collaborative Group Today - Breaking & Trending Today

Hormone Replacement Therapy and Breast Cancer: An Overview - Vimarsana News

Hormone Replacement Therapy and Breast Cancer: An Overview

The discordant findings from observational studies and randomized clinical trials affect doctors' decisions concerning hormone therapy for menopausal women.

Cureus | Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum - Vimarsana News

Cureus | Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum

A neurodegenerative disorder, Alzheimer's disease (AD), is characterized by dementia in which there is an age-related decline in cognition and higher functions. Stroke is a cerebrovascular disorder that frequently presents in old age and is a known risk factor for AD development. However, the association that AD can be a risk factor for stroke is not well-studied. This review article compiled various studies that pointed out the association between stroke development in patients with dementia, particularly AD-related dementia. The pathophysiological progression of stroke in AD cases and...

Source: cureus.com
Dairy Products Linked to Increased Risk of Cancer in Major Research Study - Vimarsana News

Dairy Products Linked to Increased Risk of Cancer in Major Research Study

TodayHeadline Dairy Products Linked to Increased Risk of Cancer in Major Research Study - SciTechDaily –

IPPF announces appointment of 8 new members to the International Medical Advisory Panel - Vimarsana News

IPPF announces appointment of 8 new members to the International Medical Advisory Panel

Since 1979, the IMAP has convened leading experts in the field of SRHR and acted as an independent advisory body on SRHR topics and as strategic support to the Federation

Source: ippf.org
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS in Lung Cancer - Vimarsana News

HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS in Lung Cancer

07.03.2022 - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 07, 2022 (GLOBE NEWSWIRE) - (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has received a US$15 million milestone payment from AstraZeneca PLC (“AstraZeneca”) ...